HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Repare Therapeutics (NASDAQ:RPTX) and maintained a $10 price target, as stated by analyst Robert Burns.
June 05, 2024 | 10:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Repare Therapeutics and maintained a $10 price target, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100